Pediatric malignancies: Is the prechemotherapy left ventricular function normal?
dc.contributor.author | Akam‐venkata, Jyothsna | |
dc.contributor.author | Kadiu, Gilda | |
dc.contributor.author | Galas, James | |
dc.contributor.author | Aggarwal, Sanjeev | |
dc.date.accessioned | 2019-10-30T15:29:57Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2019-10-30T15:29:57Z | |
dc.date.issued | 2019-09 | |
dc.identifier.citation | Akam‐venkata, Jyothsna ; Kadiu, Gilda; Galas, James; Aggarwal, Sanjeev (2019). "Pediatric malignancies: Is the prechemotherapy left ventricular function normal?." Echocardiography 36(9): 1727-1735. | |
dc.identifier.issn | 0742-2822 | |
dc.identifier.issn | 1540-8175 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/151839 | |
dc.description.abstract | PurposeWe compared the left ventricular (LV) systolic function in children with cancer before initiation of chemotherapy with matched controls using speckle tracking echocardiography.Methods and resultsIn this retrospective study, we analyzed the echocardiograms of 89 cancer patients before the initiation of chemotherapy and 82 ageâ (8.4 ± 5.2 vs. 8.9 ± 3.9 years, P = .4) and genderâ matched (64% vs. 67%, males, P = .4) healthy controls. Peak systolic LV longitudinal strain (LS) was significantly lower in cancer patients in apical two (â 19.8 ± 3.0 vs. â 23.5 ± 4.0, P < .001), three (â 19.4 ± 3.2 vs. â 23.4 ± 4.0, P < .001), and fourâ chamber views (â 19.7 ± 3.4 vs. â 22.5 ± 3.0, P < .001) compared to controls, as was global longitudinal strain (GLS) (â 19.8 ± 2.7 vs. â 23.4 ± 3.2, P < .001). The prechemotherapy group also had a higher E/e’ ratio compared to controls at the septal (9.3 ± 3.9 vs. 7.9 ± 1.7, P = .005) and lateral annulus (7.9 ± 3.3 vs. 5.9 ± 1.4, P < .001) of the mitral valve. The LV ejection fraction was lower in cancer patients compared to controls (63.5 ± 4.9 vs. 66.8 ± 4.1, P < .001), although still within normal limits. There were no differences in LV myocardial performance index (0.30 ± 0.05 vs. 0.30 ± 0.09, P < .65) and shortening fraction (35.8 ± 5.2 vs. 36.1 ± 6.1, P < 0.75) between the two groups. Subgroup analysis showed no difference in LV GLS between patients with solid tumors (n = 56) and blood cancers (n = 33) (GLS â 19.2 ± 2.9 vs. 19.5 ± 2.4, P > 0.05).ConclusionOur data demonstrating abnormalities in LV GLS in pediatric cancer patients even prior to initiation of chemotherapy are novel and perplexing. Further longitudinal followâ up is required to assess the implications of this abnormal LV function in these patients. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | pediatric echocardiography | |
dc.subject.other | malignancy | |
dc.subject.other | strain | |
dc.title | Pediatric malignancies: Is the prechemotherapy left ventricular function normal? | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/151839/1/echo14461_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/151839/2/echo14461.pdf | |
dc.identifier.doi | 10.1111/echo.14461 | |
dc.identifier.source | Echocardiography | |
dc.identifier.citedreference | Mousavi N, Tan TC, Ali M, Halpern EF, Wang L, Scherrerâ Crosbie M. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50â 59% treated with anthracyclines. Eur Heart J Cardiovasc Imaging. 2015; 16 ( 9 ): 977 â 984. | |
dc.identifier.citedreference | Sawaya H, Sebag IA, Plana JC, et al. Early detection and prediction of cardiotoxicity in chemotherapyâ treated patients. Am J Cardiol. 2011; 107 ( 9 ): 1375 â 1380. | |
dc.identifier.citedreference | Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr. 2012; 25 ( 7 ): 733 â 740. | |
dc.identifier.citedreference | Lorch SM, Ludomirsky A, Singh GK. Maturational and growthâ related changes in left ventricular longitudinal strain and strain rate measured by twoâ dimensional speckle tracking echocardiography in healthy pediatric population. J Am Soc Echocardiogr. 2008; 21 ( 11 ): 1207 â 1215. | |
dc.identifier.citedreference | Ali MT, Yucel E, Bouras S, et al. Myocardial strain is associated with adverse clinical cardiac events in patients treated with anthracyclines. J Am Soc Echocardiogr. 2016; 29 ( 6 ): pp. 522â 7 e3. | |
dc.identifier.citedreference | Negishi K, Negishi T, Hare JL, Haluska BA, Plana JC, Marwick TH. Independent and incremental value of deformation indices for prediction of trastuzumabâ induced cardiotoxicity. J Am Soc Echocardiogr. 2013; 26 ( 5 ): 493 â 498. | |
dc.identifier.citedreference | Assuncao B, Handschumacher MD, Brunner AM, et al. Acute leukemia is associated with cardiac alterations before chemotherapy. J Am Soc Echocardiogr. 2017; 30 ( 11 ): 1111 â 1118. | |
dc.identifier.citedreference | Lang RM, Badano LP, Morâ Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015; 28 ( 1 ): pp. 1â 39 e14. | |
dc.identifier.citedreference | Lopez L, Colan SD, Frommelt PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the pediatric measurements writing group of the American society of echocardiography pediatric and congenital heart disease council. J Am Soc Echocardiogr. 2010; 23 ( 5 ): pp. 465â 95; quiz 576â 7. | |
dc.identifier.citedreference | Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Ageâ specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009; 22 ( 6 ): 709 â 714. | |
dc.identifier.citedreference | Eidem BW, Sapp BG, Suarez CR, et al. Usefulness of the myocardial performance index for early detection of anthracyclineâ induced cardiotoxicity in children. Am J Cardiol. 2001; 87 ( 9 ): pp. 1120â 2, A9. | |
dc.identifier.citedreference | Gilladoga AC, Manuel C, Tan C, Wollner N, Sternberg SS, Murphy ML. The cardiotoxicity of adriamycin and daunomycin in children. Cancer. 1976; 37 ( 2 Suppl ): 1070 â 1078. | |
dc.identifier.citedreference | Charbonnel C, Conversâ Domart R, Rigaudeau S, et al. Assessment of global longitudinal strain at lowâ dose anthracyclineâ based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc Imaging. 2017; 18 ( 4 ): 392 â 401. | |
dc.identifier.citedreference | Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol. 2010; 56 ( 20 ): 1644 â 1650. | |
dc.identifier.citedreference | Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and metaâ analysis of global longitudinal strain and ejection fraction. Heart. 2014; 100 ( 21 ): 1673 â 1680. | |
dc.identifier.citedreference | Amundsen BH, Helleâ Valle T, Edvardsen T, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006; 47 ( 4 ): 789 â 793. | |
dc.identifier.citedreference | Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014; 27 ( 9 ): 911 â 939. | |
dc.identifier.citedreference | Eidem BW, McMahon CJ, Cohen RR, et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J Am Soc Echocardiogr. 2004; 17 ( 3 ): 212 â 221. | |
dc.identifier.citedreference | Honda K, Takeshita K, Murotani K, et al. Assessment of left ventricular diastolic function during trastuzumab treatment in patients with HER2â positive breast cancer. Breast Cancer. 2017; 24 ( 2 ): 312 â 318. | |
dc.identifier.citedreference | Harahsheh A, Aggarwal S, Pettersen MD, Lâ Ecuyer T. Diastolic function in anthracyclineâ treated children. Cardiol Young. 2015; 25 ( 6 ): 1130 â 1135. | |
dc.identifier.citedreference | Sivasubramanian N, Coker ML, Kurrelmeyer KM, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 2001; 104 ( 7 ): 826 â 831. | |
dc.identifier.citedreference | Roberts WC, Bodey GP, Wertlat PT. Wertlake PT. The heart in acute leukemia. A study of 420 autopsy cases. Am J Cardiol. 1968; 21 ( 3 ): 388 â 412. | |
dc.identifier.citedreference | Mertens AC, Liu Q, Neglia JP, et al. Causeâ specific late mortality among 5â year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst. 2008; 100 ( 19 ): 1368 â 1379. | |
dc.identifier.citedreference | AmericanCancerSociety. Cancer Facts & Figures 2017. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf | |
dc.identifier.citedreference | Lipshultz SE, Adams MJ, Colan SD, et al. Longâ term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013; 128 ( 17 ): 1927 â 1995. | |
dc.identifier.citedreference | Children’sOncologyGroup. Longâ Term Followâ up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer 2013, October [Version 4.0]. Available from: http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.